Complete Up To Date Information about Aureomycin / Cattlyst .
NADA Number: 141-201 | |
| Proprietary Name |
Aureomycin® / Cattlyst® |
|---|---|
| Sponsor |
Alpharma, Inc. |
| Sponsor Address |
440 Rte. 22 Bridgewater, NJ 08807 USA |
| Ingredients |
Laidlomycin Propionate Potassium Chlortetracycline |
| Species |
Cattle, beef, heifers fed in confinement for slaughter Cattle, beef, steers fed in confinement for slaughter |
| Routes of Administration |
Per Os |
| Dose Form |
Medicated feed |
| Drug Form |
Type A Medicated Article |
| Dispensing Status |
OTC |
| Withdrawal Time |
A withdrawal time for pre-ruminating veal calves has not been established. |
|
Dosage Amount, Indications & Limitations |
558.305 Laidlomycin. Specifications: Type A medicated articles containing 50 grams laidlomycin propionate potassium per pound. Labeling: All Type B and Type C feeds shall bear the following statements: Do not allow horses or other equines access to feeds containing laidlomycin propionate potassium. The safety of laidlomycin propionate potassium in unapproved species has not been established. Not for use in animals intended for breeding. Conditions of use. Species: Cattle (fed in confinement for slaughter, excluding preruminating veal calves) Amount: 5 milligrams per pound laidlomycin combined with chlortetracycline 10 milligrams per pound of body weight. Indications: For improved feed efficiency and increased rate of weigh gain; and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organism susceptible to chlortetracycline. Limitations: Feed continuously at a rate of 30 to 75 milligrams laidlomycin propionate potassium per head per day for not more than 5 days. A withdrawal period has not been established for this products in preruminating calves. Do not use in calves to be processed for veal. Amount: 5 to 10 milligrams per pound laidlomycin combined with chlortetracycline 10 milligrams per pound of body weight. Indications: For improved feed efficiency; and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organism susceptible to chlortetracycline. Limitations: Feed continuously at a rate of 30 to 150 milligrams laidlomycin propionate potassium per head per day for not more than 5 days. A withdrawal period has not been established for this products in preruminating calves. Do not use in calves to be processed for veal. Amount: 5 milligrams per pound laidlomycin combined with chlortetracycline 350 milligrams per head per day. Indications: For improved feed efficiency and increased rate of weigh gain; and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella multocida organism susceptible to chlortetracycline. Limitations: Feed continuously at a rate of 30 to 75 milligrams laidlomycin propionate potassium per head per day. A withdrawal period has not been established for this products in preruminating calves. Do not use in calves to be processed for veal. Amount: 5 to 10 milligrams per pound laidlomycin combined with chlortetracycline 350 milligrams per head per day. Indications: For improved feed efficiency and increased rate of weigh gain; and for treatment of bacterial pneumonia associated with shipping fever complex caused by Pasteurella multocida organism susceptible to chlortetracycline. Limitations: Feed continuously at a rate of 30 to 150 milligrams laidlomycin propionate potassium per head per day. A withdrawal period has not been established for this products in preruminating calves. Do not use in calves to be processed for veal. |
| Tolerances |
Tolerances are established for the sum of tetracycline residues in tissues of beef cattle, nonlactating dairy cows, calves, swine, sheep, chickens, turkeys, and duck or 2 parts per million in muscle, 6 parts per million in liver, and 12 parts per million in fat and kidney. A tolerance is established for residues of chlortetracycline in eggs of 0.4 part per million. The tolerance for parent laidlomycin (the marker residue) in the liver (the target tissue) is 0.2 part per million. |